Method of treating eosinophilia
US5096704A · kind A · utility
29Cited by
2References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 1990 |
| Grant date | Mar 17, 1992 |
| Priority date | — |
| Expiry date | Jul 23, 2010 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/866
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of preventing eosinophilia associated with certain immune disorders is provided. The method comprises administering an effective amount of an antagonist to human interleukin-5. Preferably, the antagonist is a blocking monoclonal antibody specific for human interleukin-5, or a fragment or binding composition derived therefrom.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.